Interview
ISSN 2364-2351 | A 60711 |
Life Sciences and Industry Magazine Summer Edition 2026 | Volume 25 | 20 €
David Del Bourgo, CEO of WhiteLab Genomics, on how AI is helping break barriers in CNS research
Targeted protein degradation
FREE EXCERPT
Designed to destroy
VC firms to watch
RNA technologies
Drug delivery
Europe’s life science investors shaping biotech’s next wave
From vaccines to therapeutics, RNA enters a new era
Solving the last mile for nextgeneration medicines